PCN44 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN
作者
J Castro de Carpeño,AJ Castro-Gómez,S Walzer,J Ray
出处
期刊:Value in Health [Elsevier BV] 日期:2010-11-01卷期号:13 (7): A259-A259被引量:1